Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Urine Concentrations of Vilanterol After Inhaled Administration of Vilanterol/Fluticasone Furoate: Defining a Urine Threshold and Decision Limit for Vilanterol in Doping Control Analysis

NCT03739294 is registered in ClinicalTrials.gov with Bispebjerg Hospital as lead sponsor.

NCT NCT03739294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03739294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Urine Concentrations of Vilanterol After Inhaled Administration of Vilanterol/Fluticasone Furoate: Defining a Urine Threshold and Decision Limit for Vilanterol in Doping Control Analysis
Lead sponsor
Bispebjerg Hospital
Phase
Phase 2
Overall status
Completed
Start date
February 8, 2019
Completion date
December 14, 2020
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacokinetics